Suppr超能文献

伊马替尼和索拉非尼在离体大鼠心脏纤维及心肌母细胞H9c2细胞系中引起的线粒体毒性

Mitochondrial Toxicity Associated with Imatinib and Sorafenib in Isolated Rat Heart Fibers and the Cardiomyoblast H9c2 Cell Line.

作者信息

Bouitbir Jamal, Panajatovic Miljenko V, Krähenbühl Stephan

机构信息

Division of Molecular and Systems Toxicology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland.

Division of Clinical Pharmacology & Toxicology, University Hospital, Basel, Switzerland.

出版信息

Int J Mol Sci. 2022 Feb 18;23(4):2282. doi: 10.3390/ijms23042282.

Abstract

Tyrosine kinase inhibitors (TKIs) are associated with cardiac toxicity, which may be caused by mitochondrial toxicity. The underlying mechanisms are currently unclear and require further investigation. In the present study, we aimed to investigate in more detail the role of the enzyme complexes of the electron transfer system (ETS), mitochondrial oxidative stress, and mechanisms of cell death in cardiac toxicity associated with imatinib and sorafenib. Cardiac myoblast H9c2 cells were exposed to imatinib and sorafenib (1 to 100 µM) for 24 h. Permeabilized rat cardiac fibers were treated with both drugs for 15 min. H9c2 cells exposed to sorafenib for 24 h showed a higher membrane toxicity and ATP depletion in the presence of galactose (favoring mitochondrial metabolism) compared to glucose (favoring glycolysis) but not when exposed to imatinib. Both TKIs resulted in a higher dissipation of the mitochondrial membrane potential in galactose compared to glucose media. Imatinib inhibited Complex I (CI)- and CIII- linked respiration under both conditions. Sorafenib impaired CI-, CII-, and CIII-linked respiration in H9c2 cells cultured with glucose, whereas it inhibited all ETS complexes with galactose. In permeabilized rat cardiac myofibers, acute exposure to imatinib and sorafenib decreased CI- and CIV-linked respiration in the presence of the drugs. Electron microscopy showed enlarged mitochondria with disorganized cristae. In addition, both TKIs caused mitochondrial superoxide accumulation and decreased the cellular GSH pool. Both TKIs induced caspase 3/7 activation, suggesting apoptosis as a mechanism of cell death. Imatinib and sorafenib impaired the function of cardiac mitochondria in isolated rat cardiac fibers and in H9c2 cells at plasma concentrations reached in humans. Both imatinib and sorafenib impaired the function of enzyme complexes of the ETS, which was associated with mitochondrial ROS accumulation and cell death by apoptosis.

摘要

酪氨酸激酶抑制剂(TKIs)与心脏毒性有关,这可能是由线粒体毒性引起的。其潜在机制目前尚不清楚,需要进一步研究。在本研究中,我们旨在更详细地研究电子传递系统(ETS)的酶复合物、线粒体氧化应激以及与伊马替尼和索拉非尼相关的心脏毒性中的细胞死亡机制。将心肌母细胞H9c2细胞暴露于伊马替尼和索拉非尼(1至100µM)24小时。用这两种药物处理通透的大鼠心脏纤维15分钟。与葡萄糖(有利于糖酵解)相比,暴露于索拉非尼24小时的H9c2细胞在半乳糖存在下(有利于线粒体代谢)表现出更高的膜毒性和ATP消耗,但暴露于伊马替尼时则没有。与葡萄糖培养基相比,两种TKIs在半乳糖中导致线粒体膜电位的更高消散。在两种条件下,伊马替尼均抑制复合物I(CI)和复合物III(CIII)相关的呼吸作用。索拉非尼在用葡萄糖培养的H9c2细胞中损害CI、CII和CIII相关的呼吸作用,而在用半乳糖培养时它抑制所有ETS复合物。在通透的大鼠心脏肌纤维中,急性暴露于伊马替尼和索拉非尼会在药物存在的情况下降低CI和CIV相关的呼吸作用。电子显微镜显示线粒体肿大,嵴排列紊乱。此外,两种TKIs均导致线粒体超氧化物积累并减少细胞内谷胱甘肽池。两种TKIs均诱导半胱天冬酶3/7激活,表明细胞凋亡是细胞死亡的一种机制。在人体达到的血浆浓度下,伊马替尼和索拉非尼损害了分离的大鼠心脏纤维和H9c2细胞中心脏线粒体的功能。伊马替尼和索拉非尼均损害了ETS酶复合物的功能,这与线粒体ROS积累和细胞凋亡导致的细胞死亡有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2911/8878993/3ac73d6d89d5/ijms-23-02282-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验